Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

NCT: NCT07270380 · RECRUITING

NCT IDNCT07270380
StatusRECRUITING
Start Date2026-04
Completion2028-10

Brief Summary

The purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.

Frequently Asked Questions

What is Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.?

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin. is a clinical trial registered under NCT07270380. Current status: RECRUITING.

What is the status of NCT07270380?

The current status of NCT07270380 (Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.) is: RECRUITING.

When did Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin. start?

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin. started on 2026-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑